Vav-1 regulates NK T cell development and NK cell cytotoxicity.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 11500824)

Published in Eur J Immunol on August 01, 2001

Authors

G Chan1, T Hanke, K D Fischer

Author Affiliations

1: Abteilung Physiologische Chemie, Universität Ulm, Ulm, Germany.

Articles citing this

Raising the NKT cell family. Nat Immunol (2010) 3.79

Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol (2003) 2.15

Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J Exp Med (2004) 1.39

Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. Immunity (2010) 1.25

Transcriptional control of invariant NKT cell development. Immunol Rev (2010) 1.24

Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. J Exp Med (2009) 1.14

Vav1 acidic region tyrosine 174 is required for the formation of T cell receptor-induced microclusters and is essential in T cell development and activation. J Biol Chem (2006) 1.10

Different subsets of natural killer T cells may vary in their roles in health and disease. Immunology (2014) 1.01

Translational control of NKT cell cytokine production by p38 MAPK. J Immunol (2011) 0.90

Dibutyltin activates MAP kinases in human natural killer cells, in vitro. Cell Biol Toxicol (2010) 0.88

NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation. Curr Immunol Rev (2012) 0.85

The role of p44/42 activation in tributyltin-induced inhibition of human natural killer cells: effects of MEK inhibitors. J Appl Toxicol (2009) 0.83

The adaptor molecule signaling lymphocytic activation molecule (SLAM)-associated protein (SAP) is essential in mechanisms involving the Fyn tyrosine kinase for induction and progression of collagen-induced arthritis. J Biol Chem (2013) 0.78

Signaling for synergistic activation of natural killer cells. Immune Netw (2012) 0.78

Vav1: A Dr. Jekyll and Mr. Hyde protein - good for the hematopoietic system, bad for cancer. Oncotarget (2015) 0.77

Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice. PLoS One (2015) 0.76

Antitumor Responses of Invariant Natural Killer T Cells. J Immunol Res (2015) 0.75

Articles by these authors

(truncated to the top 100)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med (1998) 4.13

A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell (1997) 3.65

Viral infections induce abundant numbers of senescent CD8 T cells. J Immunol (2001) 3.04

Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature (1997) 2.46

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. J Immunol (2000) 2.29

Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling. Nat Immunol (2001) 1.93

Lack of agreement between pulmonary arterial thermodilution cardiac output and the pressure recording analytical method in postoperative cardiac surgery patients. Br J Anaesth (2010) 1.80

Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development (1999) 1.56

CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28. Eur J Immunol (1997) 1.48

The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg (2004) 1.42

Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol (2001) 1.41

Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J Exp Med (1996) 1.34

Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol (1997) 1.27

L-phenylalanyl-tRNA synthetase of Escherichia coli K-10. A reinvestigation of molecular weight and subunit structure. Eur J Biochem (1974) 1.22

NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur J Immunol (2000) 1.21

The gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: evidence for differentiation stage-specific regulation. Mol Cell Biol (1992) 1.21

Expression of inhibitory "killer cell lectin-like receptor G1" identifies unique subpopulations of effector and memory CD8 T cells. Eur J Immunol (2001) 1.20

Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. J Exp Med (1997) 1.15

Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology (1989) 1.12

Vav regulates peptide-specific apoptosis in thymocytes. J Exp Med (1998) 1.12

Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine. Virology (2000) 1.08

Compelled weightbearing in persons with hemiparesis following stroke: the effect of a lift insert and goal-directed balance exercise. J Rehabil Res Dev (2000) 1.07

Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development. Development (1996) 1.07

Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity, but not protective efficacy against Mycobacterium tuberculosis. Immunology (1999) 1.05

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity. J Gen Virol (2001) 1.04

Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus. Virology (2000) 1.03

The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J (1995) 1.00

EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses. Neurobiol Dis (2005) 0.99

The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol Cell Biol (2001) 0.98

Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases. Ann Rheum Dis (2005) 0.98

[Recommendations of the Working Group of Arrhythmias of the German Society of Cardiology on the approach to patients with Riata® and Riata ST® leads (St. Jude Medical). Nucleus of the Working Group of Arrhythmias of the German Society of Cardiology]. Herzschrittmacherther Elektrophysiol (2012) 0.97

The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulation. Eur J Immunol (1999) 0.95

Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules. J Exp Med (2001) 0.94

Greenhouse gases: low methane leakage from gas pipelines. Nature (2005) 0.94

Is an HIV vaccine possible? Nat Med (1999) 0.93

Development of an osteoblast/osteoclast co-culture derived by human bone marrow stromal cells and human monocytes for biomaterials testing. Eur Cell Mater (2011) 0.93

Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers. Vaccine (2008) 0.93

The dynamics of the cellular immune response to HIV infection: implications for vaccination. Philos Trans R Soc Lond B Biol Sci (2000) 0.92

Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa. Gene Ther (2004) 0.91

Immunogenicity in mice of tandem repeats of an epitope from herpes simplex gD protein when expressed by recombinant adenovirus vectors. Vaccine (1993) 0.89

Inhibition of caspase-3 differentially affects vascular smooth muscle cell apoptosis in the concave versus convex aortic sites in ascending aneurysms with a bicuspid aortic valve. Ann Anat (2010) 0.85

The catalytic mechanism of amino acid:tRNA ligases. Synergism and formation of the ternary enzyme-amino acid-ATP complex. Biochemistry (1975) 0.84

Proliferation and osteogenic differentiation of human bone marrow stromal cells on alginate-gelatine-hydroxyapatite scaffolds with anisotropic pore structure. J Tissue Eng Regen Med (2009) 0.83

L-phenylalanine:tRNA ligase of Escherichia coli K10. A rapid kinetic investigation of the catalytic reaction. Biochemistry (1975) 0.83

The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart disease. Eur J Med Res (2009) 0.83

The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens. J Immunol (1999) 0.82

Effect of silica and hydroxyapatite mineralization on the mechanical properties and the biocompatibility of nanocomposite collagen scaffolds. ACS Appl Mater Interfaces (2011) 0.82

In vitro osteoclastogenesis on textile chitosan scaffold. Eur Cell Mater (2010) 0.82

Active site stoichiometry of L-phenylalanine: tRNA ligase from Escherichia coli K(-10). J Biol Chem (1975) 0.82

Impaired survival of T cell receptor V gamma 3+ cells in interleukin-4 transgenic mice. Eur J Immunol (1995) 0.82

Maturation of CD4-8- alpha/beta TCR+ T cells induced by CD2-stimulation in vivo and in vitro. Int Immunol (1992) 0.81

Equilibrium analysis of L-Phe-tRNA Phe complexes with L-phenylalanyl transfer ribonucleic acid synthetase of Escherichia coli K 10. Biochemistry (1974) 0.81

Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice. J Gen Virol (1999) 0.81

HOX genes regulate Rac1 activity in hematopoietic cells through control of Vav2 expression. Leukemia (2012) 0.80

Sequence homology between HIV-1 gp120 and the apoptosis mediating protein Fas. AIDS (1993) 0.80

Two-tag purification of recombinant proteins for the construction of solid matrix-antibody-antigen (SMAA) complexes as vaccines. Vaccine (1993) 0.79

DNA polymerase beta mRNA determination by relative quantitative RT-PCR from Leishmania infantum intracellular amastigotes. Parasitol Res (2002) 0.79

Nuclear DNA polymerase beta from Leishmania infantum. Cloning, molecular analysis and developmental regulation. Nucleic Acids Res (2001) 0.79

Calcium phosphate phases integrated in silica/collagen nanocomposite xerogels enhance the bioactivity and ultimately manipulate the osteoblast/osteoclast ratio in a human co-culture model. Acta Biomater (2012) 0.78

A new monoclonal antibody reactive with several Ly49 NK cell receptors mediates redirected lysis of target cells. Hybridoma (1999) 0.78

In vitro osteogenic potential of human bone marrow stromal cells cultivated in porous scaffolds from mineralized collagen. J Biomed Mater Res A (2009) 0.78

Specific proliferative T cell responses and antibodies elicited by vaccination with simian immunodeficiency virus Nef do not confer protection against virus challenge. AIDS Res Hum Retroviruses (2001) 0.77

A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens. J Med Primatol (2000) 0.77

Rate of paraplegia and mortality in elective descending and thoracoabdominal aortic repair in the modern surgical era. Thorac Cardiovasc Surg (2008) 0.77

Selective labelling of the beta-subunit of L-phenylalanyl-tRNA synthetase from E. coli with N-bromoacetyl-L-phenylalanyl-tRNA Phe. Biochem Biophys Res Commun (1974) 0.76

S-adenosylmethionine decarboxylase from Leishmania infantum promastigotes: molecular cloning and differential expression. Parasitol Res (2002) 0.75

[A Byzantine text on the determination of the ages of horses from Ambrosian H2 inf]. Sudhoffs Arch (1980) 0.75

Identification and cellular distribution of the rat interleukin-2 receptor beta chain: induction of the IL-2R alpha- beta+ phenotype by major histocompatibility complex class I recognition during T cell development in vivo and by T cell receptor stimulation of CD4+8+ immature thymocytes in vitro. Eur J Immunol (1996) 0.75

[Not Available]. Medizinhist J (1986) 0.75

Moses of Palermo, translator from the Arabic at the Court of Charles of Anjou. Hist Sci Med (1982) 0.75

Diagnosis and management of a massive true inferobasal ventricular aneurysm ante perforationem. Clin Res Cardiol (2006) 0.75

Rapid determination of an amino acid: tRNA ligase.aminoacyl adenylate complex on DEAE-cellulose filter disks. Anal Biochem (1976) 0.75

[Newly discovered text of Celsus on bladder diseases]. Gesnerus (1984) 0.75

Mechanism studies of enzymatically formed tolidine blue and determination of peroxidatic activities. Biomed Biochim Acta (1983) 0.75

The first Latin treatise on horse medicine and its author Pelagonius Saloninus. Medizinhist J (1981) 0.75

[Not Available]. Wurzbg Medizinhist Forsch (1982) 0.75

[A curious operation by Erasistratus or: what does "ventrem deducere" mean?]. Sudhoffs Arch (1982) 0.75

Palladius, De vet. med. 14. 15, 5. Liverp Classical Mon (1979) 0.75

[Classical verses in the medical writings of the Middle Ages]. Gesnerus (1982) 0.75

Microviscosity of water-containing heterogeneous systems. An ESR spin probe study. Biomed Biochim Acta (1985) 0.75

Does caval aplanarity influence power losses across in vitro cavopulmonary connections? Pediatr Cardiol (2002) 0.75

[Isoleucyl-tRNA-synthetase: inhibition of isoleucyladenylate synthesis due to spermine]. Hoppe Seylers Z Physiol Chem (1972) 0.75

[Not Available]. Hist Med Vet (1977) 0.75

[Resorbable bone substitution materials: An overview of commercially available materials and new approaches in the field of composites]. Orthopade (2011) 0.75

Human brain weight and acetylcholinesterase in relation to aging. Neurochem Int (1980) 0.75

[On the demonstration of circulating pathogenic agents by means of polyanetholsulfoacidic sodium (liquoid)]. Blut (1968) 0.75

[The earliest recorded eye doctor in classical antiquity]. Gesnerus (1980) 0.75

Two notes on the Hippiatrica. Greek Roman Byz Stud (Cambridge Mass) (1979) 0.75

Purification of antibody-antigen complexes containing recombinant SIV proteins: comparison of antigen and antibody-antigen complexes for immune priming. Vaccine (1994) 0.75

Cholinergic nerve fibers in bone defects of a rat osteoporosis model and their regulation by implantation of bone substitution materials. J Musculoskelet Neuronal Interact (2014) 0.75

[The health poem of Burkhard von Horneck (1522)]. Gesnerus (1988) 0.75

Ancient veterinary medicine. A survey of Greek and Latin sources and some recent scholarship. Medizinhist J (1988) 0.75

[Phenylalanyl-tRNA synthetase (PRS) from Escherichia coli: binding of substrates and effectors]. Hoppe Seylers Z Physiol Chem (1972) 0.75

Kritisches zu den "Urkunden zur Hochschulpolitik der römischen Kaiser." Medizinhist J (1979) 0.75

[Not Available]. Mittellat Jahrb (1987) 0.75

Phenylalanyl-tRNA synthetase from E. coli: synergistic coupling between the sites for binding of L-phenylalanine and ATP. Biochem Biophys Res Commun (1973) 0.75

Ein weiteres spätantikes Zeugnis für die Zahnzahl der Eunuchen. Medizinhist J (1985) 0.75

"Three lexicographical notes." Glotta (1979) 0.75

Mechanisms of excitatory actions of neurotensin on canine small intestinal circular muscle in vivo and in vitro. Can J Physiol Pharmacol (1987) 0.75

[Seneca the Elder, Controversiae 10,5,17: an overlooked reference in the history of ancient anatomy]. Sudhoffs Arch (1984) 0.75